» Articles » PMID: 11850859

Survival of Patients with Pulmonary Tuberculosis: Clinical and Molecular Epidemiologic Factors

Overview
Journal Clin Infect Dis
Date 2002 Feb 19
PMID 11850859
Citations 59
Authors
Affiliations
Soon will be listed here.
Abstract

Using restriction fragment-length polymorphism data, we conducted a retrospective cohort study of 139 adult patients with pulmonary tuberculosis to investigate the clinical impact of Mycobacterium tuberculosis infection with a clustered isolate. The cumulative all-cause mortality rate during treatment was 21%. Patients with clustered DNA fingerprint patterns had a reduced risk of death, compared with patients with unique patterns (hazard ratio [HR], 0.5; 95% confidence interval [CI], 0.2-1.1), but this finding was confounded by age (adjusted HR, 0.8; 95% CI, 0.4-1.8). After adjustment for age, the strongest predictors of death were such underlying illnesses as diabetes mellitus, renal failure, chronic obstructive pulmonary disease, and human immunodeficiency virus infection. We conclude that comorbidity and immunosuppression are important predictors of survival for patients with pulmonary tuberculosis in an inner-city cohort. Recently transmitted infection, as determined by use of DNA fingerprinting to classify patients' isolates as being either clustered or unique, was not independently associated with death.

Citing Articles

Long-term outcomes of the global tuberculosis and COVID-19 co-infection cohort.

Casco N, Jorge A, Palmero D, Alffenaar J, Fox G, Ezz W Eur Respir J. 2023; 62(5).

PMID: 37827576 PMC: 10627308. DOI: 10.1183/13993003.00925-2023.


Epidemiology of tuberculosis in Kazakhstan: data from the Unified National Electronic Healthcare System 2014-2019.

Sakko Y, Madikenova M, Kim A, Syssoyev D, Mussina K, Gusmanov A BMJ Open. 2023; 13(10):e074208.

PMID: 37821138 PMC: 10582847. DOI: 10.1136/bmjopen-2023-074208.


Deaths from tuberculosis: differences between tuberculosis-related and non-tuberculosis-related deaths.

Jeong Y, Park J, Kim H, Min J, Ko Y, Oh J Front Public Health. 2023; 11:1207284.

PMID: 37719730 PMC: 10502314. DOI: 10.3389/fpubh.2023.1207284.


Diabetes Mellitus and Tuberculosis Treatment Outcomes: Interaction Assessment Between Hyperglycemia and Human Immunodeficiency Virus in the State of Georgia, 2015-2020.

Houck K, Chakhaia T, Gorvetzian S, Critchley J, Schechter M, Magee M Open Forum Infect Dis. 2023; 10(6):ofad255.

PMID: 37383249 PMC: 10295156. DOI: 10.1093/ofid/ofad255.


Evaluations of Factors Affecting of Short-and Long-Time of Occurrence of Disease Relapse in Patients with Tuberculosis Using Parametric Mixture Cure Model: A Cohort Study.

Kazempour-Dizaji M, Varahram M, Tabarsi P, Roozbahani R, Zare A, EmamHadi M Tanaffos. 2022; 21(1):70-77.

PMID: 36258908 PMC: 9571239.